Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

UH15-38

Copy Product Info
😃Good
Catalog No. T88101Cas No. 2540881-21-6

UH15-38 is a potent and selective RIPK3 inhibitor that blocks necroptosis in alveolar epithelial cells triggered by IAV, useful for studying lung inflammation.

UH15-38

UH15-38

Copy Product Info
😃Good
Purity: 99.85%
Catalog No. T88101Cas No. 2540881-21-6
UH15-38 is a potent and selective RIPK3 inhibitor that blocks necroptosis in alveolar epithelial cells triggered by IAV, useful for studying lung inflammation.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$123In StockIn Stock
5 mg$297In StockIn Stock
10 mg$496In StockIn Stock
25 mg$993In StockIn Stock
50 mg$1,590In StockIn Stock
100 mg$2,550-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.85%
Appearance:Solid
Color:Yellow
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
UH15-38 is a potent and selective RIPK3 inhibitor that blocks necroptosis in alveolar epithelial cells triggered by IAV, useful for studying lung inflammation.
Targets&IC50
RIPK3:20 nM
In vitro
UH15-38 significantly reduces the incidence of necrosis within type I alveolar epithelial cells (AEC), thereby minimizing the pro-inflammatory environment in the lungs. [1]
In vivo
In mouse models of severe IAV infection, UH15-38 significantly inhibited lung damage. By inhibiting RIPK3-MLKL signaling, it reduced the number of necrotic cells within the lung parenchyma, particularly type I AECs, without affecting the frequency of apoptotic cells. [1]
Chemical Properties
Molecular Weight441.53
FormulaC26H27N5O2
Cas No.2540881-21-6
SmilesO=C1C(=CC=2C=NC(=CC2N1C)NC3=CC=CC(=C3)N4CCN(C)CC4)C5=CC=CC(O)=C5
Storage & Solubility Information
Storagekeep away from moisture,store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 80 mg/mL (181.19 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 5 mg/mL (11.32 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.2649 mL11.3243 mL22.6485 mL113.2426 mL
5 mM0.4530 mL2.2649 mL4.5297 mL22.6485 mL
10 mM0.2265 mL1.1324 mL2.2649 mL11.3243 mL
20 mM0.1132 mL0.5662 mL1.1324 mL5.6621 mL
50 mM0.0453 mL0.2265 mL0.4530 mL2.2649 mL
100 mM0.0226 mL0.1132 mL0.2265 mL1.1324 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy UH15-38 | purchase UH15-38 | UH15-38 cost | order UH15-38 | UH15-38 chemical structure | UH15-38 in vivo | UH15-38 in vitro | UH15-38 formula | UH15-38 molecular weight